Summary of Study ST001399

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000959. The data can be accessed directly via it's Project DOI: 10.21228/M8QX3V This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Study ID	ST001399
Study Title	Activation of ectopic olfactory receptor 544 induces GLP-1 secretion, alters gut microbiome, and improves intestinal permeability.
Study Type	Fecal metabolome
Study Summary	Metabolome data set from mouse fecal samples Group - WT_AZA: fecal samples from wild type mouse fed with high fat diet and azelaic acid (0.05%, w/w) Group - WT_DW: fecal samples from wild type mouse fed with high fat diet Group - KO_AZA: fecal samples from Olfr544 receptor knock out mouse fed with high fat diet and azelaic acid (0.05%, w/w) Group - KO_DW: fecal samples from Olfr544 receptor knock out mouse fed with high fat diet
Institute	Korea University
Last Name	Kim
First Name	Jungyeon
Address	145, Anam-ro, Seongbuk-gu, Seoul, Seoul, 02841, Korea, South
Email	kim131812@korea.ac.kr
Phone	821082248015
Submit Date	2020-06-07
Raw Data Available	Yes
Raw Data File Type(s)	cdf
Analysis Type Detail	GC-MS
Release Date	2020-06-30
Release Version	1

Select appropriate tab below to view additional metadata details:

Treatment:

Treatment ID:	TR001488
Treatment Summary:	The mice were fed on 60% high fat diet (HFD) for 4 weeks and subsequently randomly assigned into the test or vehicle group. HFD used in this study is rodent diet containing 60% of calories from fat (D12492, Research Diets, Inc). The mice in the test group were fed with a HFD and 0.05% (w/w) AzA for 6 weeks or a HFD and orally administered AzA (50 mg/kg body weight) for 8 weeks. The former feeding was to confirm antiobesogenic effects of AzA in diet and the latter was to investigate microbiome and metabolomic analyses. The mice in the vehicle group were administered ddH2O. The body weight and food intake of the mice were measured twice a week. Mice were fasted overnight before being sacrificed.

Treatment ID:

TR001488

Treatment Summary:

The mice were fed on 60% high fat diet (HFD) for 4 weeks and subsequently randomly assigned into the test or vehicle group. HFD used in this study is rodent diet containing 60% of calories from fat (D12492, Research Diets, Inc). The mice in the test group were fed with a HFD and 0.05% (w/w) AzA for 6 weeks or a HFD and orally administered AzA (50 mg/kg body weight) for 8 weeks. The former feeding was to confirm antiobesogenic effects of AzA in diet and the latter was to investigate microbiome and metabolomic analyses. The mice in the vehicle group were administered ddH2O. The body weight and food intake of the mice were measured twice a week. Mice were fasted overnight before being sacrificed.